SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Atrion Corporation ATRI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Atrion Corporation (ATRI) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $459.92. It has a SharesGrow Score of 52/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Financials: revenue is $169M, +5.1%/yr average growth. Net income is $19M, growing at -11.9%/yr. Net profit margin is 11.5% (healthy). Gross margin is 36.8% (-8 pp trend).

Balance sheet: total debt is $240,000 against $243M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 9.09 (strong liquidity). Debt-to-assets is 0.1%. Total assets: $261M.

Analyst outlook: 0 / 1 analysts rate ATRI as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 40/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 35/100 (Fail), Future 20/100 (Fail), Income 55/100 (Partial).

ATRI SharesGrow Score Overview

52/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

VALUE 15/100

Valuation — P/E, PEG, Forward PEG

GROWTH 40/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 35/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 55/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ATRI

ATRI trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

ATRI: +5.1%/yr revenue is, -11.9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

ATRI: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet ATRI: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 9.09 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

ATRI: Gross margin is 36.8% (-8 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 35/100. ≥ 70 = Pass.

View details →

Analyst outlook: 0 / 1 analysts rate ATRI as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

ATRI: Net profit margin is 11.5%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range274.98-503.24

Volume29.52K

Avg Volume (30D)27.6K

Market Cap$809.44M

Beta (1Y)0.69

Dividend Yield$8.8000

Share Statistics

EPS (TTM)11.02

Shares Outstanding$1.76M

IPO Date1980-03-18

Employees712

CEODavid A. Battat

Financial Highlights & Ratios

Revenue (TTM)$169.33M

Gross Profit$62.39M

EBITDA$37.68M

Net Income$19.41M

Operating Income$22.58M

Total Cash$6.26M

Total Debt$240K

Net Debt$-3.33M

Total Assets$260.83M

Price / Earnings (P/E)41.7

Price / Sales (P/S)4.78

Analyst Forecast

Rating ConsensusSell

Analysts Covering1

Buy 0% Hold 0% Sell 100%

Company Info

CountryUS

ExchangeNASDAQ Global Select

CurrencyUSD

ISINUS0499041053

Price Chart

ATRI

Atrion Corporation ↗ · NASDAQ Global Select

Healthcare • Medical - Instruments & Supplies

274.98 52WK RANGE 503.24

People Also View

The Cooper Companies, Inc.

AptarGroup, Inc.

Envista Holdings Corp

Merit Medical Systems, Inc.

ICU Medical, Inc.

Haemonetics Corporation

AngioDynamics, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message